EU Watchdog Urges Vaccine Developers Not to Focus Only on Omicron

The European Union drugs regulator said pharmaceuticals companies should work on more than one upgraded COVID-19 shot, not only tailored to the fast-emerging Omicron variant but also versions that address a combination of variants.
Reuters Health Information

source https://www.medscape.com/viewarticle/966764?src=rss